Dali Pharmaceuticalco.,Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 39.82 million compared to CNY 49 million a year ago. Revenue was CNY 39.82 million compared to CNY 49 million a year ago. Net loss was CNY 3.21 million compared to net income of CNY 0.189613 million a year ago. Basic loss per share from continuing operations was CNY 0.0146 compared to basic earnings per share from continuing operations of CNY 0.0009 a year ago. Diluted loss per share from continuing operations was CNY 0.0146 compared to diluted earnings per share from continuing operations of CNY 0.0009 a year ago.